<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Rojo-Carrillo JJ</submitter><funding>Centro de Investigación Biomédica en red de Enfermedades Raras, Spain</funding><funding>Fundación Española de Trombosis y Hemostasia</funding><funding>Instituto de Salud Carlos III</funding><funding>Ministerio de Ciencia e Innovación</funding><pagination>1148</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11603882</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>25(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Protein-coding genes have been considered the functional part of the genome, although they represent only 2% of the genome. In contrast, more than 90% of the genome produces non-coding RNA (ncRNA), including antisense (AS) genes, a type of long non-coding genes (encoding transcripts > 200 nucleotides) located on the opposite strand of coding genes. Therefore, antisense RNA (asRNA) can be complementary to the counterpart sense RNA, supporting a regulatory role with potential pathogenic consequences, as their deregulation has been associated with cardiovascular disease, cancer, and diabetes.&lt;h4>Results&lt;/h4>We performed an in-depth review of AS genes in Ensembl and evaluated the expression of AS genes in human liver by third-generation RNA sequencing methods. Currently, 165</pubmed_abstract><journal>BMC genomics</journal><pubmed_title>Landscape of antisense genes in the human genome and identification of new human hepatic antisense RNAs by long-read sequencing.</pubmed_title><pmcid>PMC11603882</pmcid><funding_grant_id>RYC2021-031000-I</funding_grant_id><funding_grant_id>PI21/00174</funding_grant_id><funding_grant_id>Predoctoral fellowship</funding_grant_id><funding_grant_id>CB15/00055</funding_grant_id><funding_grant_id>PMP21/00052</funding_grant_id><pubmed_authors>Padilla J</pubmed_authors><pubmed_authors>Llamas-Lopez M</pubmed_authors><pubmed_authors>Lozano ML</pubmed_authors><pubmed_authors>Garrido-Rodriguez P</pubmed_authors><pubmed_authors>de la Morena-Barrio ME</pubmed_authors><pubmed_authors>Rojo-Carrillo JJ</pubmed_authors><pubmed_authors>Ramos-Molina B</pubmed_authors><pubmed_authors>Cifuentes-Riquelme R</pubmed_authors><pubmed_authors>de la Morena-Barrio B</pubmed_authors><pubmed_authors>Corral J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Landscape of antisense genes in the human genome and identification of new human hepatic antisense RNAs by long-read sequencing.</name><description>&lt;h4>Background&lt;/h4>Protein-coding genes have been considered the functional part of the genome, although they represent only 2% of the genome. In contrast, more than 90% of the genome produces non-coding RNA (ncRNA), including antisense (AS) genes, a type of long non-coding genes (encoding transcripts > 200 nucleotides) located on the opposite strand of coding genes. Therefore, antisense RNA (asRNA) can be complementary to the counterpart sense RNA, supporting a regulatory role with potential pathogenic consequences, as their deregulation has been associated with cardiovascular disease, cancer, and diabetes.&lt;h4>Results&lt;/h4>We performed an in-depth review of AS genes in Ensembl and evaluated the expression of AS genes in human liver by third-generation RNA sequencing methods. Currently, 165</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Nov</publication><modification>2026-06-02T05:02:31.991Z</modification><creation>2025-04-04T00:46:20.158Z</creation></dates><accession>S-EPMC11603882</accession><cross_references><pubmed>39604851</pubmed><doi>10.1186/s12864-024-11017-3</doi></cross_references></HashMap>